RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
Mar. 26, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Jul. 28, 2016 |
|
| Director [Member] | ||||
| Compensation and interest payable | $ 1,448,722 | $ 1,271,685 | ||
| BioCorRx Inc. [Member] | ||||
| Common stock shares issued in exchange | 2,263,371 | |||
| Ownership interest | 12.15% | |||
| BioCorRx Pharmaceuticals [Member] | ||||
| Ownership retained percent | 75.80% | |||
| Ownership interest | 24.20% |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|